Probing the in-vivo reservoir of latent tuberculosis infection.
| Autor: | Lalvani A; NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College London, London W2 1PG, UK. Electronic address: a.lalvani@imperial.ac.uk., Fenn J; NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College London, London W2 1PG, UK., Pillay TD; NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College London, London W2 1PG, UK. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Lancet. Microbe [Lancet Microbe] 2021 Jun; Vol. 2 (6), pp. e226-e227. Date of Electronic Publication: 2021 Mar 31. |
| DOI: | 10.1016/S2666-5247(21)00080-X |
| Abstrakt: | Competing Interests: AL reports issued patents underpinning IGRA and next-generation IGRA some of which were assigned by the University of Oxford to Oxford Immunotec resulting in royalty entitlements for the University of Oxford and AL. All other authors declare no competing interests. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|